Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: Wortmannin-sensitive inhibition by insulin

Endocrinology

Volumn 140, Issue 1, 1999, Pages 398-404

  McIntosh, Christopher H S ^a   Bremsak, Irene ^a   Lynn, Francis C ^a   Gill, Ruth ^a   Hinke, Simon A ^a   Gelling, Richard ^a   Nian, Cuilan ^a   McKnight, Gary ^b   Jaspers, Stephen ^b   Pederson, Raymond A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ZYMOGENETICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; INSULIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; RECEPTOR PROTEIN; WORTMANNIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIPOLYSIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032895556     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.1.6464     Document Type: Article

References (47)

1. 1. Brown JC, Buchan AMJ, McIntosh CHS, Pederson RA 1989 Gastric inhibitory polypeptide. In: Schultz SG, Makhlouf GM, Rauner BB (eds) Handbook of Physiology, Section 6 (The Gastrointestinal System). American Physiology Society, Bethesda, pp 403-430
2. 2. Pederson RA 1993 Gastric inhibitory polypeptide. In: Walsh J, Dockray G (eds) Gut Peptides. Raven Press, New York, pp 217-259
3. 3. Habener JF 1993 The incretin notion and its relevance to diabetes. Endocrinol Metab Clin North Am 22:775-794
4. 4. Gutniak MK, Holst JJ, Linde B, Efendic S 1994 Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM. Diabetes Care 17:1039-1044
5. 5. McGarry JD 1998 Glucose-fatty acid interactions in health and disease. Am J Clin Nutr [ 67:500S-504S
6. 6. Ross SA, Shaffer EA 1981 The importance of triglyceride hydrolysis for the release of gastric inhibitory polypeptide. Gastroenterology 80:108-111
7. 7. Yoshidome K, Miyata M, Izukura M, Mizutani S, Sakamoto T, Tominaga H, Matsuda H 1995 Secretion of gastric inhibitory polypeptide in patients with bile duct obstruction. Scand J Gastroenterol 30:586-589
8. 8. Ebert R, Creutzfeldt W 1980 Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Diabetologia 19:198-204
9. 9. O'Dorisio TM, Cataland S, Stevenson M, Mazzaferri EL 1976 Gastric inhibitory polypeptide (GIP). Intestinal distribution and stimulation by amino acids and medium-chain triglycerides. Am J Dig Dis 21:761-765
10. 10. Beck B 1989 Gastric inhibitory polypeptide: a gut hormone with anabolic functions. J Mol Endocrinol 2:169-174
11. 11. Wasada T, McCorkle K, Harris V, Kawai K, Howard B, Unger RH 1981 Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs. J Clin Invest 68:1106-1107
12. 12. Ebert R, Nauck M, Creutzfeldt W 1991 Effect of exogenous or endogenous gastric inhibitory polypeptide (GIP) on plasma triglyceride responses in rats. Horm Metab Res 23:517-521
13. 13. Eckel RH, Fujimoto WY, Brunzell JD 1979 Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes. Diabetes 28:1141-1142
14. 14. Hauner H, Glatting G, Kaminska D, Pfeiffer EF 1988 Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes. Ann Nutr Metab 32:282-288
15. 15. Ebert R, Creutzfeldt W 1987 Metabolic effects of gastric inhibitory polypeptide. Front Horm Res 16:175-185
16. 16. Dupre J, Greenidge N, McDonald TJ, Ross SA, Rubinstein D 1976 Inhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptide. Metabolism 25:1197-1199
17. 17. Wheeler MB, Gelling RW, McIntosh CHS, Georgiou J, Brown JC, Pederson RA 1995 Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide (GIP) receptor: ligand binding and intracellular signaling properties. Endocrinology 136:4629-4639
18. 18. Gelling RW, Wheeler MB, Xue J, Gyomorey S, Nian C, Pederson RA, McIntosh CHS 1997 Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor. Endocrinology 138:2640-2642
19. 19. Yeaman SJ 1990 Hormone-sensitive lipase-a multipurpose enzyme in lipid metabolism. Biochim Biophys Acta 1052:128-132
20. 20. Rosen OM, Smith CJ, Hirsch A, Lai E, Rubin CS 1979 Recent studies of the 3T3-L1 adipocyte-like cell line. Recent Prog Horm Res 35:477-499
21. 21. Rentsch J, Chiesi M 1996 Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett 379:55-59
22. 22. Chomczynski P, Sacchi N 1987 Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
23. 23. Wieland O 1974 Glycerol U.V. method. In: Burgmeyer HU (ed) Methods of Enzymatic Analysis. Academic Press, New York, vol 4:1404-1409
24. 24. McIntosh CHS, Wheeler MB, Gelling RW, Brown JC, Pederson RA 1996 GIP receptors and signal-transduction mechanisms. Acta Physiol Scand 157:361-365
25. 25. Lai E, Rosen OM, Rubin CS 1981 Differentiation-dependent expression of catecholamine-stimulated adenylate cyclase. Roles of the β-receptor and G/F protein in differentiating 3T3-L1 adipocytes. J Biol Chem 256:12866-12874
26. 26. Kawamura M, Jensen DF, Wancewicz EV, Joy LL, Khoo JC, Steinberg D 1981 Hormone-sensitive lipase in differentiated 3T3-L1 cells and its activation by cyclic AMF-dependent protein kinase. Proc Natl Acad Sci USA 78:732-736
27. 27. Elks ML, Manganiello VC, Vaughan MJ 1983 Hormone-sensitive participate cAMP phosphodiesterase activity in 3T3-L1 adipocytes. Regulation of responsiveness by dexamethasone. J Biol Chem 258:8582-8587
28. 28. Hirsch AH, Rosen OM 1984 Lipolytic stimulation modulates the subcellular distribution of hormone-sensitive lipase in 3T3-L1 cells. J Lipid Res 25:665-677
29. 29. Montrose-Rafizadeh C, Yang H, Wang Y, Roth J, Montrose MH, Adams L G 1997 Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes. J Cell Physiol 172:275-283
30. 30. Wang Y, Kole HK, Montrose-Rafizadeh C, Perfetti R, Bernier M, Egan J M 1997 Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions. J Mol Endocrinol 19:241-248
31. 31. Grupp G, Grupp IL, Johnson CL, Matlib MA, Rouslin W, Schwartz A, Wallick ET, Wang T, Wisler P 1980 Effects of RMI 12330A, a new inhibitor of adenylate cyclase on myocardial function and subcellular activity. Br J Pharmacol 70:429-442
32. 32. Simpson AM, Tuch BE 1995 Control of insulin biosynthesis in the human fetal beta cell. Pancreas 11:48-54
33. 2+-dependent induction of serotonin N-acetyltransferase activity. Neurochem Int 27:147-155
34. 34. Flakoll P, Carlson MG, Cherrington A 1996 Physiologic action of insulin. In: LeRoith D, Taylor SI, Olefsky JM (eds) Diabetes Mellitus. Lippincott-Raven, Philadelphia, pp 121-132
35. 35. Degerman E, Belfrag P, Manganiello VC 1997 Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem 272:6823-6826
36. 36. Strålfors P, Honnor RC 1989 Insulin-induced dephosphorylation of hormone-sensitive lipase. Correlation with lipolysis and cAMP-dependent protein kinase activity. Eur J Biochem 182:379-385
37. 37. Karoor V, Baltensperger K, Paul H, Czech MP, Malbon CC 1995 Phosphorylation of tyrosyl residues 350/354 of the β-adrenergic receptor is obligatory for counterregulatory effects of insulin. J Biol Chem 270:25305-25308
38. 38. Baltensperger K, Karoor V, Paul H, Ruoho A, Czech MP, Malbon CC 1996 The β-adrenergic receptor is a substrate for the insulin receptor tyrosine kinase. J Biol Chem 271:1061-1064
39. 39. Geahlen R, Harrison ML 1990 Protein-tyrosine kinases. In: Kemp BE (ed) Peptides and Protein Phosphorylation. CRC Press, Boca Baton, FL, pp 239-253
40. 40. Lam K, Carpenter CL, Ruderman NB, Friel JC, Kelly KL 1994 The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by wortmannin. J Biol Chem 269:20648-20652
41. 2+]i and a wortmannin-sensitive signalling pathway. Biochem Biophys Res Commun 224:369-374
42. 42. Kubota A, Yamada Y, Yasuda K, Someya Y, Ihara Y, Kagimoto S, Watanabe R, Kuroe A, Ishida H, Seino Y 1997 Gastric inhibitory polypeptide activates MAP kinase through the wortmannin-sensitive and -insensitive pathways. Biochem Biophys Res Commun 236:171-175
43. 43. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M 1994 Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with the selective inhibitor wortmannin. J Biol Chem 269:3568-3573
44. 44. Evans JL, Honer CM, Womelsdorf BE, Kaplan EL, Bell PA 1995 The effects of wortmannin, a potent inhibitor of phosphatidyl-inositol 3-kinase, on insulin-stimulated glucose transport, GLUT4 translocation, antilipolysis, and DNA synthesis. Cell Signal 7:365-376
45. 45. White MF 1997 The insulin signalling system and the 1RS proteins. Diabetologia 40:S2-S17
46. 46. Toker A, Cantley LC 1997 Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673-676
47. 47. Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, Daniels MB, Chen S, McGany JD 1996 Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728-2735